Pine Haven Investment Counsel’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Other funds holding IDXX
MBI
CGI
CAM
RG
SIM
BPCE
MJRIC
RP
Pine Haven Investment Counsel's IDXX Position: Q2 2026 in Review
Pine Haven Investment Counsel increased its Idexx Laboratories (IDXX) stake by 4.8% in Q2 2026, buying an estimated $35.3K and bringing the position to 1,388 shares worth $731K. The position accounts for 0.49% of the portfolio, ranked #57.
Pine Haven Investment Counsel first reported a position in IDXX in Q4 2021 and has held it in 19 quarters since. The position peaked at $885K in Q4 2025. 330 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Pine Haven Investment Counsel held 1,388 shares of Idexx Laboratories worth $731K as of Q2 2026.
- Pine Haven Investment Counsel bought 63 Idexx Laboratories shares in Q2 2026, an estimated $35.3K.
- Idexx Laboratories made up 0.49% of Pine Haven Investment Counsel's portfolio in Q2 2026, its #57 holding.
- Pine Haven Investment Counsel first reported a position in Idexx Laboratories in Q4 2021 and has held it in 19 quarters since.
- Pine Haven Investment Counsel's Idexx Laboratories position peaked at $885K in Q4 2025.
- 330 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Pine Haven Investment Counsel's 13F filing for Q2 2026, filed 8 Jul 2026.